Table 1 Clinical characteristics of total 197 patients with cervical cancer
From: Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Characteristics | No. of patients (%) |
|---|---|
Total case | 197 |
Age (years) | |
 Median, range | 44, 28–79 |
  ≤ 44 | 106 (53.8%) |
  > 44 | 91 (46.2%) |
Gender | |
 Male | 0 (0%) |
 Female | 197 (100.0%) |
Pathological tumor (T) statusa | |
 T1 | 147 (74.6%) |
 T2–4 | 50 (25.4%) |
Pathological node (N) statusa | |
 N0 | 173 (87.8%) |
 N1 | 24 (12.2%) |
Pathological metastasis (M) statusa | |
 M0 | 197 (100.0%) |
 M1 | 0 (0%) |
Clinical stageb | |
 I | 127 (64.5%) |
 II–IV | 70 (35.5%) |
Death | |
 No | 171 (86.8%) |
 Yes | 26 (13.2%) |
Therapy after surgery | |
 Surgery alone | 45 (22.8%) |
 Radiation therapy alone | 41 (20.8%) |
 Surgery & radiation therapy | 27 (13.7%) |
Surgery& radiation therapy & chemotherapy | 84 (42.6%) |